Joseph Pergolizzi, Jr, MD

Co-founder, CEO, other
NEMA, Neumentum, Enalare, Advantx, other
Naples, Florida

Presentation(s):

• Poster Number-6 - A Rapid Review of Non-Invasive Electromagnetic Devices for the Treatment of Pain

  Poster Abstracts

• Poster Number-60 - A Systematic Chemical Design Strategy Leads to NTM-004/005, an Acetaminophen Structural Analog with Minimal Liver Histopathology

  Poster Abstracts

• Poster Number-61 - ADV-484, a Novel Selective Inhibitor of alpha2delta-1 for the Treatment of Neuropathic Pain

  Poster Abstracts

• Poster Number-62 - ADV-502, a Novel Dual Sigma-1 Receptor Antagonist and Mu-Opioid Receptor Agonist for the Treatment of Pain: I. Discovery and Preclinical Evaluation

  Poster Abstracts

• Poster Number-63 - ADV-502, a Novel Dual Sigma-1 Receptor Antagonist and Mu-Opioid Receptor Agonist for the Treatment of Pain: II. Tolerance and Opioid-Induced Hyperalgesia

  Poster Abstracts

• Poster Number-64 - ADV-502, a Novel Dual Sigma-1 Receptor Antagonist and Mu-Opioid Receptor Agonist for the Treatment of Pain: III. Phase-1 Study

  Poster Abstracts

• Poster Number-75 - Cocaethylene: When Cocaine Meets Alcohol

  Poster Abstracts

• Poster Number-59 - The Agnostic Respiratory Stimulant ENA-001 Demonstrates Preliminary Positive Results in an Animal Model of Apnea of Prematurity

  Poster Abstracts

• Poster Number-76 - The Heat is On: When Hot Weather Hurts

  Poster Abstracts

• Poster Number-58 - Update on NTM-006, a Novel Orally-Active Non-Opioid Analgesic: Molecular-Modeling Consistent with Allosteric Modulation of the Adenosine A3 Receptor

  Poster Abstracts

• Poster Number-77 - When an Old Drug Brings New Challenges: Nitazenes

  Poster Abstracts